- Home
- OCEA vs FLGC Comparison
OCEA vs FLGC Comparison
Compare OCEA & FLGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCEA
- FLGC
- Stock Information
- Founded
- OCEA 2019
- FLGC 2019
- Country
- OCEA United States
- FLGC United States
- Employees
- OCEA N/A
- FLGC N/A
- Industry
- OCEA Biotechnology: Pharmaceutical Preparations
- FLGC Biotechnology: Pharmaceutical Preparations
- Sector
- OCEA Health Care
- FLGC Health Care
- Exchange
- OCEA Nasdaq
- FLGC Nasdaq
- Market Cap
- OCEA 30.4M
- FLGC 26.5M
- IPO Year
- OCEA N/A
- FLGC 2021
- Fundamental
- Price
- OCEA $0.72
- FLGC $1.17
- Analyst Decision
- OCEA
- FLGC Strong Buy
- Analyst Count
- OCEA 0
- FLGC 3
- Target Price
- OCEA N/A
- FLGC $6.50
- AVG Volume (30 Days)
- OCEA 48.2K
- FLGC 533.2K
- Earning Date
- OCEA 11-26-2024
- FLGC 11-13-2024
- Dividend Yield
- OCEA N/A
- FLGC N/A
- EPS Growth
- OCEA N/A
- FLGC N/A
- EPS
- OCEA N/A
- FLGC N/A
- Revenue
- OCEA N/A
- FLGC $64,154,000.00
- Revenue This Year
- OCEA N/A
- FLGC N/A
- Revenue Next Year
- OCEA N/A
- FLGC $19.90
- P/E Ratio
- OCEA N/A
- FLGC N/A
- Revenue Growth
- OCEA N/A
- FLGC N/A
- 52 Week Low
- OCEA $0.52
- FLGC $0.70
- 52 Week High
- OCEA $7.79
- FLGC $2.93
- Technical
- Relative Strength Index (RSI)
- OCEA 29.58
- FLGC 40.65
- Support Level
- OCEA $0.83
- FLGC $1.11
- Resistance Level
- OCEA $1.00
- FLGC $1.63
- Average True Range (ATR)
- OCEA 0.06
- FLGC 0.18
- MACD
- OCEA -0.02
- FLGC -0.05
- Stochastic Oscillator
- OCEA 24.93
- FLGC 6.67
About OCEA Ocean Biomedical Inc.
Ocean Biomedical Inc is a biopharmaceutical company. It is dedicated towards partnering with inventor-scientists and research institutes to bridge the gap between basic research and clinical development, to get new medicines to the patients who need it most.
About FLGC Flora Growth Corp.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are; the commercial and wholesale segment (FGH and Cosechemos subsidiaries), the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries), and the pharmaceuticals segment (Grupo Farmaceutico Cronomed and Breeze Laboratory subsidiaries). Geographically, the company generates revenue from United States, Germany, and the United Kingdom. It derives a majority of its revenue from the United States.